ClinicalTrials.gg
CompletedNCT07297537Updated Nov 9, 2026

Adductor Endurance Test: Validity and Reliability

An interventional study of Hip Adductor Endurance and Strength Testing in Groin Injury, Hip Injuries and Athletic Injuries, sponsored by Izmir Democracy University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Izmir Democracy University · Not applicable, Interventional, and Other

Updated Nov 9, 2026Now CompletedEnrollment updated+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
310
Allocation
Not applicable
Ages
18 Years to 30 Years
Sex
All
01

Study summary

Groin and hip injuries are common in team sports-especially soccer, rugby, and ice hockey-and frequently affect male and young athletes. About 14% of all sports injuries involve the groin and hip region, with most related to the adductor muscles. These injuries often increase during congested match periods and may result in athletes missing 1 to 6.9 weeks of training or competition, extending up to 14 weeks when surgery is required. Weakness in the adductor muscles is a key risk factor for groin injuries, and current assessments primarily measure maximal strength using tools such as squeeze tests, sphygmomanometers, or dynamometers. However, muscle endurance-critical because many injuries occur under fatigue-has not been adequately studied, and no validated endurance tests for the hip adductors exist. This study aims to evaluate the validity and reliability of a newly developed hip adductor endurance test for monitoring endurance strength in professional soccer players.

Read the detailed description

Groin and hip injuries are common in various team sports such as soccer, rugby, and ice hockey, and are particularly prevalent among male athletes and young athletes aged 15-24 . Studies show that approximately 14% of all injuries occur in the groin and hip regions, and 63% of these are directly related to the adductor muscles . Furthermore, these injuries increase during periods when matches are played at frequent intervals. Research conducted by the Union of European Football Associations (UEFA) within the scope of the Champions League has reported an injury rate of 1.1 per 1,000 match hours for this type of injury. A significant consequence of these injuries is that players are unable to participate in training or matches for an average of 1 to 6.9 weeks ; when surgical intervention is required, this period can extend up to 14 weeks . This situation strains the financial resources of clubs and negatively affects the overall performance of the team . Given the importance of these injuries, it is crucial to regularly monitor athletes' health and take protective measures when necessary . Weakness in the adductor muscles is an important risk factor in predicting groin and hip injury risk. Adductor muscle strength measurements are usually performed using the hip adductor squeeze test, which is both accurate and reliable. During the test, a measuring device is placed between the player's knees, and they are asked to squeeze their legs together. Research has shown that decreased adductor muscle strength may indicate a risk of groin pain development in soccer players. Furthermore, it has been reported that previously injured athletes have weaker adductor muscles compared to uninjured athletes before the season. This information has led to the development of new monitoring methods to detect early signs of muscle weakness in athletes throughout the season and to initiate strengthening exercises. Therefore, the availability and development of easily applicable tests to determine muscle strength may be beneficial for coaches and physical therapists in preventive interventions.

Various technologies such as sphygmomanometers, isometric dynamometers, and isokinetic dynamometers are used to measure adductor strength. In these measurements, peak force variables obtained during isometric contraction of the adductor muscles are recorded. However, all of these methods have been developed to assess the maximum muscle strength of the adductor muscles. Since the vast majority of muscle injuries develop after muscle fatigue, assessing the muscles' ability to resist force over a long period of time may be indicative in predicting muscle injuries. However, there are no studies in the scientific literature on tests used to measure muscle endurance, which is the ability of the hip adductor muscles to resist prolonged force.

The aim of this study is to examine the validity and reliability of the hip adductor endurance test, which will be used to measure hip adductor endurance strength in professional soccer players.

02

Conditions studied

  • Groin Injury
  • Hip Injuries
  • Athletic Injuries

Keywords

  • Hip adductor muscles
  • Adductor endurance
  • Sports injuries
  • Validity
  • Reliability
03

In context

Hip Injuries

66 studies on the registry are indexed under Hip Injuries; 12 are open to participants now.

This study's enrollment of 310 is above the median of 61 across 40 interventional studies indexed under Hip Injuries.

Browse Hip Injuries studies →

Lead sponsor

Izmir Democracy University is the lead sponsor of 78 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between 18 and 30 years of age
  • Being a professional soccer player for at least four years
  • Actively participating in training sessions
  • Scoring >87.5 points on the hip and groin injury questionnaire (HAGOS) sports subscale

Exclusion criteria

Exclusion Criteria:

  • Having any orthopedic injury involving the lower extremities that would prevent participation in training sessions
  • Experiencing pain rated four or higher on the numerical pain rating scale during the hip adductor squeeze test and palpation of the adductor muscle tendons.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
310 participants (actual)

Study arms

  • Experimental
    Test Group

    Participants perform the Hip Adductor Endurance Test and GroinBar isometric strength test in randomized order.

    Other: Hip Adductor Endurance and Strength Testing

Interventions

  • OtherHip Adductor Endurance and Strength Testing

    Participants will perform the Hip Adductor Endurance Test to assess adductor muscle endurance, followed by isometric maximum force assessment using the fixed dynamometer (GroinBar) . Tests are conducted in randomized order before routine training sessions, after a 5-minute light aerobic warm-up and dynamic stretching

06

What researchers measure

Primary outcomes

  1. Pain Assessment

    Pain felt during the adductor squeeze test and adductor palpation test, which are applied for inclusion/exclusion criteria, will be assessed using the Numerical Pain Rating Scale. The patient will be asked to mark the level of pain they feel on a 10 cm line, and the marked location will then be measured with a ruler and recorded.

    Time frame: baseline

  2. Evaluation of Maximum Isometric Muscle Strength of the Hip Adductor Muscles

    Hip adductor strength of both lower extremities will be assessed simultaneously using the GroinBar fixed dynamometer (VALD Performance, Australia), a highly reliable method (ICC=0.94). Strength will be measured in two positions: short lever arm (hips 60°, knees 90° flexed, force applied at medial knee epicondyles) and long lever arm (hips and knees extended, force applied 5 cm proximal to medial malleoli). Athletes perform three 5-second maximal isometric contractions per position, with 5-10 seconds rest between repetitions and 20-30 seconds between positions. A trial at 80% of maximal effort is allowed before measurement. Verbal encouragement is provided, and the highest values in Newtons (N) for both dominant and non-dominant legs are recorded; strength ratios are subsequently calculated.

    Time frame: baseline

  3. Hip Adductor Endurance Test

    Hip adductor endurance will be assessed using a time-based version of the Copenhagen Adduction Exercise, which elicits high adductor activation. Participants lie on their side, lift their body concentrically, hold the isometric position as long as possible, and lower eccentrically. The test focuses on maintaining correct alignment and endurance duration rather than maximal force, converting the Copenhagen exercise into an endurance assessment protocol.

    Time frame: baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in Sep 2026, 5 months.

Of 26 non-industry interventional studies with no phase under Hip Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 65. This study's 5 months is below that.

Counting every sponsor, half of 28 studies reached it within 26 months; a quarter within 8 and three quarters within 65.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2025
First posted
Dec 22, 2025
StartActual
Apr 15, 2026
Primary completionActual
Sep 15, 2026
CompletionActual
Oct 15, 2026
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Nov 9, 2026
Sites
1 site added, 1 site removed
Show site
  • Izmir Democracy Univercity · Izmir, Turkey (Türkiye)
Show 1 removed
  • Izmir Democracy Univercity · Izmir, Turkey (Türkiye)
Nov 9, 2026
Enrollment
18 (estimated)→310 (actual)
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Not yet recruiting→Completed
    1 site added, 1 site removed
    Show site
    • Izmir Democracy Univercity · Izmir, Turkey (Türkiye)
    Show 1 removed
    • Izmir Democracy Univercity · Izmir, Turkey (Türkiye)
    Enrollment 18 (estimated)→310 (actual)
    + 3 other changes: verification date, date precision and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07297537
Lead sponsor
Izmir Democracy University
Responsible party
Ferruh Taşpınar (Prof. Dr., Izmir Democracy University) — Principal investigator
First posted
Dec 22, 2025
Start date
Apr 15, 2026
Primary completion
Sep 15, 2026
Completion
Oct 15, 2026
Last update
Nov 9, 2026

Study contacts

Betül Taspinar, Prof.Dr.
principal investigator · Izmir Democracy University
Ayşe Sezgi Kızılırmak Karataş, Pt.PhD
study director · Izmir Democracy University
Mesut Buğday, Pt.
study director · Göztepe Sports Club

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion